ADM opens new animal microbiome research centre
Swiss facility will study pet and livestock health solutions
27 June 2025
2 minute read
By: ADM has opened a new research and development (R&D) centre focused on advancing research into animal microbiomes and developing targeted products for pets, livestock and aquaculture, according to a company press release.
The 1,600-square-metre facility, located at the Biopôle life science campus in Lausanne, Switzerland, will support pre-clinical research into the use of biotics and fermentation-derived ingredients to address animal health challenges.
“We are seeing significant growth in the global pet and farm animal microbiome market, as farmers and pet owners alike seek science-backed nutrition solutions to support the health and well-being of their pets and livestock,” said Nuria Miquel, senior vice president and chief science officer at ADM.
“The centre will use advanced scientific and technological tools to increase our understanding of the gut microbiome’s role in broader pet and animal health, and support our development of microbiome solutions to bring to market.”
The global market for biotics in animal feed was valued at an estimated $5.2 billion in 2024. The gut microbiome is linked to immune, digestive and absorptive functions, influencing both animal health and production efficiency.
Pet owners are also increasingly looking for functional products to support their animals’ long-term health. A global survey found that 84% of pet owners across 22 countries are interested in products that may help extend their pet’s lifespan.
ADM’s research network has studied the effects of pre-, pro- and postbiotics on companion animal health. Findings include postbiotic support for healthy blood sugar levels in adult dogs, intestinal health support in cats undergoing dietary changes, oral health benefits in dogs, and skin health support using postbiotic blends.
More information on ADM's animal and pet nutrition research is available at adm.com.
